The second zone is supported by a marker located in the NAV3 gene, on chromosome 12, which encodes a navigator neuron associated with some types of cancer and could be a good prognostic gene and therapeutic target (Carlsson et al. 2013). This evidence concerns the gene NAV3 and cancer.